We found that rapamycin-induced reprogramming was reduced by knockdown of AKT1 or IRS1 (Fig. 4e), while knockdown of AKT1 or IRS1 only did not reprogram breast cancer cells into iFLs. Here, IRS1 is linked to breast cancer.